Endocrinology
29. May 2013
Menopause, estrogens and frailty
The controversy surrounding the results from the Women's Health Initiative (WHI) trials published a decade ago caused a significant decline in the use of menopausal hormone replacement therapy. However, these results have been vehemently contested and several lines of evidence suggest that in perime…
Read the publication
Journal:
Authors:
- Nedergaard A,
- Henriksen K,
- Karsdal MA,
- Christiansen C,
Bone, Osteoporosis
28. Oct 2012
Recommendations on the management of fragility fracture risk in women younger than 70 years
The risk for fragility fracture represents a problem of enormous magnitude. It is estimated that only a small fraction of women with this risk take the benefit of preventive measures. The relationship between estrogen and bone mass is well known as they are the other factors related to the risk for …
Read the publication
Journal:
Authors:
- Palacios S,
- Christiansen C,
- Sánchez Borrego R,
- Gambacciani M,
- Hadji P,
- Karsdal MA,
- Lambrinoudaki I,
- Lello S,
- O'Beirne B,
- Romao F,
- Rozenberg S,
- Stevenson JC,
- Ben-Rafael Z,